Survival analyses showed that high GREM1 expression (score of ≥3) and high ISLR expression (score of ≥2) were independent prognostic factors for poor and favorable disease-free survival, respectively, in patients with rectal cancer (Figure 2D and Supplementary Tables 2 and 3). The gene discussed is GREM1; the disease is rectal cancer.